Clinical Trials Logo

Vulvar Intraepithelial Neoplasia clinical trials

View clinical trials related to Vulvar Intraepithelial Neoplasia.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06297187 Active, not recruiting - Clinical trials for Condylomata Acuminata

Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study

Start date: February 23, 2024
Phase:
Study type: Observational

The study is a single arm, retrospective, single-center, post market registry. The purpose of this Registry is to collect data to demonstrate the safety and performance of CUSA® for the treatment of Vulvar Intraepithelial Neoplasia (VIN) and condyloma acuminata.

NCT ID: NCT04704908 Active, not recruiting - Cervical Cancer Clinical Trials

Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m)

Start date: February 6, 2021
Phase:
Study type: Observational

The primary objective of this study is to evaluate the immuno-persistence (type specific IgG antibody) of the tested vaccine administered in girls aged 9-17 years,comparing to young healthy adults of 18-26 years who received the standard 3-dose schedule (0,1,6 months).

NCT ID: NCT02140021 Active, not recruiting - Clinical trials for Cervical Intraepithelial Neoplasia

Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer

Start date: October 27, 2014
Phase: N/A
Study type: Interventional

This trial studies the prevalence of anal dysplasia and anal cancer in patients with cervical, vaginal, and vulvar dysplasia and cancer. Studying samples collected from patients in the laboratory may help doctors learn more about the human papillomavirus and how often anal cancer occurs in patients with cervix, vagina, or vulvar cancer.